Chronic Fatigue Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Chronic Fatigue Syndrome, including details on myalgic encephalomyelitis (me), diagnosis, gradual and sudden onset.

Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.

Schönfeldt-Lecuona C, Connemann BJ, Wolf RC, Braun M, Freudenmann RW

While psychoeducational strategies and general support are always indicated for the treatment of chronic fatigue syndrome (CFS), pharmacological strategies are yet not well established. Antidepressants such as selective serotonin re-uptake inhibitors have been shown to influence positively symptoms and immunological parameters. However, a considerable part of CFS patients do not satisfactorily respond to them. Bupropion, a centrally acting catecholamine-transporter blocker without classic psycho-analeptic properties, shows theoretical potential to improve fatigue symptoms. In the reported case paroxetine was augmented with bupropion at high dosage, a strategy which consecutively led to a rapid relief of CFS-symptoms.

Published 27 July 2006 in Pharmacopsychiatry, 39(4): 152-4.
Full-text of this article is available online (may require subscription).

© 2005-2008 Chronic Fatigue Syndrome Research Today. All Rights Reserved.